Search for: "Watson Laboratories Inc." Results 61 - 80 of 177
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
1 Apr 2016, 5:30 am by Gene Quinn
The FTC’s complaint alleges that Endo paid the first generic companies that filed for FDA approval – Impax Laboratories, Inc. and Watson Laboratories, Inc. [read post]
28 Mar 2007, 7:00 pm
In its two dozenth precedential decision of 2007, the Trademark Trial and Appeal Board affirmed a Section 2(e)(4) refusal to register the mark WATSON for "computer software for use in laboratory information management ... [read post]
26 Aug 2012, 9:00 pm by Patent Docs
Watson Laboratories, Inc. 3:12-cv-05228; filed August 20, 2012 in the District Court of New Jersey Infringement of U.S. [read post]
9 Mar 2014, 9:31 pm by Patent Docs
• Defendants: Actavis plc; Actavis, Inc.; Watson Laboratories, Inc.; Actavis Pharma, Inc. [read post]
5 Dec 2017, 12:29 pm by Overhauser Law Offices, LLC
., Actavis Laboratories UT, Inc., FKA Watson Laboratories Inc., Lupin Pharmaceuticals, Inc., and Lupin LTD infringed patent no. 8,435,944, Method and Composition for Transdermal Drug Delivery (the ‘944 patent) and 8,807,861, Spreading Implement, (the ‘861 patent), which have been issued by the US Patent Office. [read post]
24 Nov 2016, 8:23 pm by Kate Howard
Watson Laboratories, Inc. 16-493 Issue: Whether the “on sale” bar found in Section 102(b) of the Patent Act applies only to sales or offers of sale made available to the public, as Congress, this court, and the United States have all made clear, or whether it also applies to non-public sales or offers of sale, as the U.S. [read post]
2 Dec 2009, 11:05 am by dbmadmin
On December 2, 2009, the FTC announced an order settling charges that Watson Pharmaceuticals, Inc. [read post]
6 Feb 2013, 4:43 pm by Mandour & Associates
Watson Pharmaceuticals Inc. and Impax Laboratories Inc. both sent letters to Purdue in December, informing the company of their plans to make a generic form of the drug. [read post]
10 Mar 2013, 9:59 pm by Patent Docs
Searle LLC; Pfizer Asia Pacific PTE, LTD.; • Defendants: Lupin Pharmaceuticals, Inc.; Teva Pharmaceuticals USA, Inc.; Mylan Pharmaceuticals Inc.; Watson Laboratories, Inc.; Apotex Inc.; Apotex Corp. [read post]
4 Oct 2015, 9:08 pm by Patent Docs
Watson Laboratories, Inc. 3:15-cv-05723; filed July 22, 2015 in the District Court of New Jersey Infringement of U.S. [read post]
24 Dec 2008, 9:04 am
Earlier, Schering and Sepracor have similar settlement agreements with generic manufacturers including Ranbaxy, Perrigo Co. and Watson Pharmaceuticals Inc. [read post]
25 Feb 2011, 7:12 am by Phil
(collectively "Shire") have received a new Paragraph IV Notice Letter from Watson Laboratories, Inc. in Fort Lauderdale, Florida ("Watson") advising of the filing of an Abbreviated New Drug Application ("ANDA") for a generic version of all approved strengths of Shire's ADDERALL XR(R) (mixed salts of a single-entity amphetamine product) dextroamphetamine sulphate, dextroamphetamine saccharate, amphetamine aspartate monohydrate,… [read post]
8 Dec 2010, 6:07 pm by Larry Jones
Other GnRH drugs include Watson Pharmaceuticals Inc's Trelstar and Endo Pharmaceuticals Holdings Inc's Vantas. [read post]
9 Oct 2009, 9:11 am
Watson Pharmaceuticals Inc., Watson Laboratories, Inc. and Watson Pharma Inc. [read post]